trial · primary record
6MW5311
AML
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 122 |
| Primary completion | 2029-12 |
| Primary endpoint | Number of participants with dose-limiting toxicities (DLTs) |
| Registry ID | NCT07914556 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:48.245Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07914556
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.